# Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions

> **NCT07272187** · — · RECRUITING · sponsor: **Herlev Hospital** · enrollment: 138 (estimated)

## Conditions studied

- Insulinoma; Pancreas
- MEN1
- NETs
- Radiofrequency Ablation
- Endoscopic Ultrasound (EUS)
- Conn Syndrome

## Interventions

- **OTHER:** observational study

## Key facts

- **NCT ID:** NCT07272187
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2040-12-31
- **Final completion:** 2041-12-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272187, "Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07272187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*